KROS logo
KROS

Keros Therapeutics Inc

Biotechnology

Keros Therapeutics Inc (KROS) Earnings

Last reported
April 30, 2026
EPS estimate
-$1.11
EPS actual
Revenue est.
$510.0K
Revenue actual